Decision pending on diabetes medications
Should new medicines to treat type 2 diabetes be funded?
Should more than 50,000 people receive funding for the drugs?
Government drug-funding agency Pharmac is expected to decide next week whether it will fund two new medicines to treat type 2 diabetes.
Botany resident Graham King and thousands of other people who suffer from the condition hope the decision will fall in their favour.
King (pictured) pays $100 a month for Dapagliflozin, which is used to treat the condition.
Despite the cost, he said it helps control his diabetes and has cut the amount of insulin he has to take.
He said he doesn't think people should endure what he has had to to get modern medicines, like Dapagliflozin, Empagliflozin and Dulaglutide, to treat the condition.
"I'm just lucky I can afford $100 a month."
Figures released by the Ministry of Health last year showed there were 45,266 people registered in the Counties Manukau area with type 2 diabetes in 2019.
Pharmac chief executive Sarah Fitt said that next week its board will look at funding both Empagliflozin and Dulaglutide for 50,000 New Zealanders with type two diabetes who have a high risk of complications such as heart and kidney disease.
"Clinical experts told us that there is evidence for significant benefit from these two medicines in people with established or at high risk of cardiovascular and/or renal disease," she said.
Poll: 🤖 What skills do you think give a CV the ultimate edge in a robot-filled workplace?
The Reserve Bank has shared some pretty blunt advice: there’s no such thing as a “safe” job anymore 🛟😑
Robots are stepping into repetitive roles in factories, plants and warehouses. AI is taking care of the admin tasks that once filled many mid-level office jobs.
We want to know: As the world evolves, what skills do you think give a CV the ultimate edge in a robot-filled workplace?
Want to read more? The Press has you covered!
-
53.9% Human-centred experience and communication
-
14.4% Critical thinking
-
29.1% Resilience and adaptability
-
2.6% Other - I will share below!
Poll: Should complete designs be shared with the public, or should the community help shape the designs from the start?
The Post recently shared an opinion piece on the Harbour Crossing and why a more democratic approach might be needed 🚗🚲👟
While most decisions sit within the political arena, many organisations—like NZTA—manage long-term projects that go beyond party lines. Politics can sometimes disrupt progress, and the next Harbour Crossing is a big decision that will affect all Aucklanders.
We’d love your thoughts: Should near-complete, shovel-ready designs be shared with the public, or should the community have a hand in shaping the designs from the start?
-
80.8% Community feedback and transparency is needed.
-
19.2% No. This would be impossible in practice.
Have you got New Zealand's best shed? Show us and win!
Once again, Resene and NZ Gardener are on the hunt for New Zealand’s best shed! Send in the photos and the stories behind your man caves, she sheds, clever upcycled spaces, potty potting sheds and colourful chicken coops. The Resene Shed of the Year 2026 winner receives $1000 Resene ColorShop voucher, a $908 large Vegepod Starter Pack and a one-year subscription to NZ Gardener. To enter, tell us in writing (no more than 500 words) why your garden shed is New Zealand’s best, and send up to five high-quality photos by email to mailbox@nzgardener.co.nz. Entries close February 23, 2026.
Loading…
